These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6378561)

  • 21. Nonlinear dependence of biological activity on hydrophobic character: the bilinear model.
    Kubinyi H
    Farmaco Sci; 1979 Mar; 34(3):248-76. PubMed ID: 43264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic parameters: which are necessary to define a drug substance?
    Benet LZ
    Eur J Respir Dis Suppl; 1984; 134():45-61. PubMed ID: 6586486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using pharmacokinetics in drug therapy II: Rapid estimates of dosage regimens and blood levels without knowledge of pharmacokinetic variables.
    Schumacher GE; Griener JC
    Am J Hosp Pharm; 1978 Apr; 35(4):454-9. PubMed ID: 645719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model.
    Staahl C; Upton R; Foster DJ; Christrup LL; Kristensen K; Hansen SH; Arendt-Nielsen L; Drewes AM
    J Clin Pharmacol; 2008 May; 48(5):619-31. PubMed ID: 18440921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective on covalent binding and toxicity.
    Gillette JR; Pohl LR
    J Toxicol Environ Health; 1977 Mar; 2(4):849-71. PubMed ID: 853542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine.
    Boström E; Hammarlund-Udenaes M; Simonsson US
    Anesthesiology; 2008 Mar; 108(3):495-505. PubMed ID: 18292687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The highly permeable blood-brain barrier: an evaluation of current opinions about brain uptake capacity.
    Fagerholm U
    Drug Discov Today; 2007 Dec; 12(23-24):1076-82. PubMed ID: 18061888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primer on clinical pharmacokinetics.
    Bauer LA
    Am J Hosp Pharm; 1983 Oct; 40(10):1637-41. PubMed ID: 6638025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing brain free fraction in early drug discovery.
    Read KD; Braggio S
    Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):337-44. PubMed ID: 20102287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of computers in pharmacokinetics.
    Danek A
    Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):345-50. PubMed ID: 689793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamic principles in chemical teratology: dose-effect relationships.
    Jusko WJ
    J Pharmacol Exp Ther; 1972 Dec; 183(3):469-80. PubMed ID: 4636387
    [No Abstract]   [Full Text] [Related]  

  • 32. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
    Usansky HH; Sinko PJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Practical evaluation of methods in pharmacokinetics].
    Rupp W
    Arzneimittelforschung; 1975 Jul; 25(7a):1148-52. PubMed ID: 1242344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational prediction of oral drug absorption based on absorption rate constants in humans.
    Linnankoski J; Mäkelä JM; Ranta VP; Urtti A; Yliperttula M
    J Med Chem; 2006 Jun; 49(12):3674-81. PubMed ID: 16759110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Some fundamental concepts of pharmacokinetic practice].
    Perrier CV; Griessen M
    Pharm Acta Helv; 1974; 49(7-8):217-28. PubMed ID: 4462123
    [No Abstract]   [Full Text] [Related]  

  • 36. Modelling of the pharmacodynamics and pharmacodynamic interactions of CNS active drugs.
    Danhof M; Mandema JW
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):516-9. PubMed ID: 1490817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of the relation between pharmacokinetic processes and pharmacological effects in humans].
    Dorokhov VV; Kholodov LE
    Farmakol Toksikol; 1985; 48(5):119-25. PubMed ID: 3908140
    [No Abstract]   [Full Text] [Related]  

  • 38. [Biochemical action mechanisms and pharmacokinetics of psychoactive drugs].
    Matussek N; Greil W
    Arzneimittelforschung; 1975 Jul; 25(7a):1178-84. PubMed ID: 1101905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.
    Meibohm B; Derendorf H
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):401-13. PubMed ID: 9352388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiologic pharmacokinetic models: relevance, experience, and future trends.
    Rowland M
    Drug Metab Rev; 1984; 15(1-2):55-74. PubMed ID: 6378562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.